Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in <scp>IBD</scp>

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply

Published:2024-05-10 Issue:12 Volume:59 Page:1646-1647
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Aliu Arta¹²^ORCID,Bosch Daan H. C. A.¹²^ORCID,Keszthelyi Daniel¹²^ORCID,Ardabili Ashkan Rezazadeh¹²^ORCID,Colombel Jean‐Frederic³^ORCID,Sawyer Rachel⁴,Törnblom Hans⁵^ORCID,Hart Ailsa⁶^ORCID,Jonkers Daisy M. A. E.¹²^ORCID,Pierik Marieke J.¹²^ORCID,Mujagic Zlatan¹²^ORCID

Affiliation:

1. Department Gastroenterology and Hepatology Maastricht University Medical Center Maastricht The Netherlands

2. NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences Maastricht University Maastricht The Netherlands

3. Department of Medicine, The Henry D. Janowitz Division of Gastroenterology Icahn School of Medicine at Mount Sinai New York New York USA

4. IBD Patient Advocacy, Founder of the Bottom Line IBD and IBD Women London UK

5. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

6. IBD Unit St Mark's Hospital & Imperial College London UK

Abstract

LINKED CONTENTThis article is linked to Aliu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17988 and https://doi.org/10.1111/apt.18027.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18031

Reference10 articles.

1. Review article: a practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission;Aliu A;Aliment Pharmacol Ther,2024

2. Letter: intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD;Leong RW;Aliment Pharmacol Ther,2024

3. The intestinal barrier, an arbitrator turned provocateur in IBD

4. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders

5. Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial